Inderpaul S Sehgal
Overview
Explore the profile of Inderpaul S Sehgal including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
70
Citations
486
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sehgal I, Muthu V, Dhooria S, Prasad K, Garg M, Rudramurthy S, et al.
J Allergy Clin Immunol Pract
. 2025 Mar;
PMID: 40088971
Background: The impact of bronchiectasis severity on the outcomes of patients with allergic bronchopulmonary aspergillosis (ABPA) remains uncertain. Objective: To evaluate whether bronchiectasis severity is associated with an increased risk...
2.
Agarwal R, Sehgal I, Muthu V
Lung India
. 2025 Feb;
42(2):79-83.
PMID: 40013623
No abstract available.
3.
Singh G, Hanumanthappa M, Agarwal R, Rudramurthy S, Prabhakar N, Muthu V, et al.
Lung India
. 2024 Dec;
42(1):61-64.
PMID: 39718921
No abstract available.
4.
Chacko B, Chaudhry D, Peter J, Khilnani G, Saxena P, Sehgal I, et al.
Indian J Crit Care Med
. 2024 Oct;
28(10):989.
PMID: 39411300
No abstract available.
5.
Chacko B, Chaudhry D, Peter J, Khilnani G, Saxena P, Sehgal I, et al.
Indian J Crit Care Med
. 2024 Sep;
28(Suppl 2):S67-S91.
PMID: 39234233
How To Cite This Article: Chacko B, Chaudhry D, Peter JV, Khilnani G, Saxena P, Sehgal IS, . isccm Position Statement on the Approach to and Management of Critically Ill...
6.
Kumar S, Sharma A, Prasad K, Sehgal I, Dhooria S, Agarwal R, et al.
Lung India
. 2024 May;
41(2):143-145.
PMID: 38700410
No abstract available.
7.
Sehgal I, Agarwal R, Jindal A, Siddiqui M, Mohan A, Pal A, et al.
Lung India
. 2024 May;
41(2):84-92.
PMID: 38700400
Background: Mycobacterium w (Mw), an immunomodulator, resulted in better clinical status in severe coronavirus infectious disease 19 (COVID-19) but no survival benefit in a previous study. Herein, we investigate whether...
8.
Phadnis S, Muthu V, Sehgal I, Prasad K, Dhooria S, Aggarwal A, et al.
J Asthma
. 2024 Mar;
61(10):1242-1247.
PMID: 38520686
Background: The utility of two disease-severity indices, namely bronchiectasis severity index (BSI) and FACED score in allergic bronchopulmonary aspergillosis (ABPA) remains unknown. Objective: To correlate the BSI and FACED scores...
9.
Neubock M, Gunther G, Barac A, Davidsen J, Laursen C, Agarwal R, et al.
Semin Respir Crit Care Med
. 2024 Jan;
45(1):102-113.
PMID: 38196060
Post-tuberculosis lung disease (PTLD) has only recently been put in the spotlight as a medical entity. Recent data suggest that up to 50% of tuberculosis (TB) patients are left with...
10.
Agarwal R, Muthu V, Sehgal I
Semin Respir Crit Care Med
. 2023 Dec;
45(1):114-127.
PMID: 38154470
Allergic bronchopulmonary aspergillosis (ABPA) is a complex hypersensitivity reaction to airway colonization by in patients with asthma and cystic fibrosis. The pathophysiology of ABPA involves a complex interplay between the...